0% found this document useful (0 votes)
13 views3 pages

Synthesis Matrix Blank2

Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
13 views3 pages

Synthesis Matrix Blank2

Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 3

2. Literature 10.

Implications
Ref Vol #, Issue #, 4. Sample/ 5. Study design/ 6. Variables/ 7. Results/
1. Authors Year Article title Journal title type (qual, 3. RQ/ Purpose 8. Strengths 9. Limitations for research and
# pp. doi # Population Method instruments Findings
quant, or mixed) practice
1 Goldsworthy 202 Impact of a Journal of the 5(3):302-309. mixed The primary 762 patients vaccination quasi- total of 2575 The
J, Benzer J, 2 pharmacist-led American doi:10.1002/ja purpose of this under the outreach expermental patients at 2 pharmacist
Salvati L pneumococcal College of c5.1542 article is to outreach program study MHPP office vaccination
vaccination Clinical assess how program. through 984 patients program
outreach Pharmacy much impact telephone were excluded significantly
program in a the calls 1591 patients increased the
primary care pharmacist-led included in the rate of PPSV23
setting vaccination study vaccination in
outreach (54.1% vs two primary
program had 60.5%, care offices.
overall in the P<0.001.)
primary care
setting.
2 Laura L. John, 202 Evaluation of a Journal of Vol. 0(0) I-5 mixed The purpose 715 patients REDCap web-based Results of the There is a
PharmD, 3 Pharmacist-led Pharmacy of this study eligible to Survery software study did not need to
Inpatient COVID-19 Practice was to see recieve platform show a great increase
Pharmacy Vaccination how well the vaccination. 23 increase, but vaccination
Program in a COVID-19 (3.2%) patients pharmacists rates to help
Hospital vaccination received and pharmacy combat the
Setting administration vaccine wile students have COVID-19
would work impatient. the unique pandemic.
well with opportunity to
pharmacists administer the
leading. COVID-19
vaccination to
the inpatient
population.
3 Jason J. 202 Exploring Taylor & Vol. 26, NO.3, mixed To see what older African PPPP was an 15-item 190 older PPPP impacted sustain efforts Support for
Schafer, 1 beliefs about Francis Group 364-378 the PPPP has Americans, educational instrument adults; the beliefs may be pharmacist
Jacquelyn pneumococcal an impact on 190 older intervention assessed female(76.3%) after the needed to educational
McRae, vaccination in the adults delivered participants’ , African program very reinforce services in
Katherine M. a pneumonia participated using a senior beliefs at American(80.5 positively, these gains. senior centers
Prioli predominantly vaccination in center model baseline, post- %) regarding the should be
older African a older African of care test, and three mean age:74.3 pneumococcal considered.
American American consisting of a months across years disease,
population: population. formal four domains statistically pharmacists
the pharmacist significant and
Pharmacists’ presentation improvements pharmacies,
Pneumonia live skit, small in beliefs at and
Prevention group action post-test vaccination
Program planning, and
(PPPP) optional PV.
4 Mark A. 201 Pharmacy and Journal of the doi: qualitative The purpose population five core social and with increased how much Public health
Strand, 4 public health: American 10.1331/JAPh of this article health in competencies behavioral clarity of the student can benefit
Donald R. A pathway Pharmacists A.2014.13145 was to point general of public science, health role of public pharmacists from the
Miller forward Association out how health. policy and health, and have participation
practicing administration mastery of the demonstrated of pharmacy.
pharmacists , five core in their
can support epidemiology, competencies interest in
public health biostatistics, of public public health
initiatives by environmental health, initiatives.
using the five health pharmacists
core sciences can make
competencies unique and
of public valuable
health. contributions
to the health
of the public.
5 Cherokee 202 US Community JAMA Health 4(6):e23583. qualitative The purpose 300 million data collected The more the US
Layson-Wolf, 3 Pharmacies Forum doi:10.1001/ja of this article doses of throughout pharmacists community
Joshua M. and Public mahealthforu was to point COVID-19 the pandemic. helped with pharmacists
Sharfstein Health- m.2023.2583 out how much vaccines not only
Building on the US Covid-19, but
the Covid-19 community with HIV
Response pharmacists hypertension,
played a role overdose, and
in the COVID- reproductive
19 pandemic. health care,
the more good
results they
have.
6 Paul O. 201 Potential for Wolters Volume 23, mixed To provide the general pharmacy- PubMd, With the everything. Regulatory Pharmacy-
Gubbins, 7 Pharmacy- Kluwer Health, Number 6 how much population based CLIA- Google Scholar evidence they variance in based CLIA-
Pharm D, Public Health Inc. potential waived POCT have, how some waived POCT
Micheal E. Collaborations pharmacists services for pharmacists states apply services for
Klepser, Alex using can infectious that CLIA and infectious
J. Adams, pharmacy- collaborate diseases. collaborate pharmacy diseases offer
David M. based point- with public with other practices. much
Jacobs of-care testing health healthcare CLIA-waived potential for
services for professionals professionals POC tests future
infectious using can leverage cannot be pharmacy-
diseases pharmacy- the knowledge performed in public health
based services. of infectious any site collaborations.
disease. without the
CMS
Certificate of
Waiver.
7 Daniel J. 201 The opioid Am J Health- Vol 71 mixed How U.S sales of prescription Pharmacists in everything.
Cobaugh, Carl 4 abuse and Syst Pharm pharmacists prescription drug hospitals and
Gainor, misuse can help to opioids monitoring health systems
Cynthia L. epidemic: ensure the increased programs can play a key
Gaston, Tai C. Implications safety of fourfold from role in
Kwong for opioid use. 1999 to 2010 recognizing
pharmacists in the various
hospitals and forms of
health systems opioid toxicity.
8 Emma 201 Development Journal of the S118-S122 mixed How Kentucky population of planning and Of the everything. was unable to
Palmer, Steve 6 and delivery of American pharmacists Kentucky, promotion of pharmacists directly asses
Hart, Patricia a pharmacist Pharmacists helped the 1320 the APPKC trained, 1029 how many
R. Freeman training Association dispensation pharmacists member (78%) have pharmacists
program to and delivery of and 348 organizations. received have
increase naloxone student naloxone- implemented
naloxone pharmacists certified naloxone
access in were trained. status. 87% of protocols, as
Kentucky learners Kentucky law
ranking the doesn’t
usefulness of require
the pharmacists to
information report this
presented as information to
excellent. the KBP.
9 Hadi A. 202 Health Saudi 529-537 qualitative How population of
Almansour, 0 consumer Pharmaceutica pharmacists people with
Nouf M. engagement in l Journal play a role in cardiovascular
Aloudah, developing cardiovascular disease in
Tariq M. novel disease in Saudi Arabia.
Alhawassi preventive Saudi Arabia.
health
community
pharmacy
roles in
cardiovascular
disease in
Saudi Arabia:
A qualitative
analysis
10
11
12
13
14
15

You might also like